Eric Fossel

Company: Viska Bio

Job title: Chief Executive Officer

Seminars:

Introducing the Successes of Antibody Enzyme Conjugates with Oxidized LDL as a Novel Payload in Inactivated P53 Tumors 3:30 pm

Introducing data compared to traditional ADCs for a new therapeutic agent – an antibody enzyme conjugate or AEC Introducing a new payload – oxidized LDL generated in the tumor micro environment Demonstrating independence from p53 through showing efficacy in both p53 active and inactive tumorsRead more

day: Conference Day One